{"id":186791,"date":"2025-11-13T17:49:44","date_gmt":"2025-11-13T16:49:44","guid":{"rendered":"https:\/\/www.gpigroup.com\/?p=186791"},"modified":"2025-11-13T17:50:42","modified_gmt":"2025-11-13T16:50:42","slug":"gpi-group-acquires-logiprem-f","status":"publish","type":"post","link":"https:\/\/www.gpigroup.com\/en\/news\/gpi-group-acquires-logiprem-f\/","title":{"rendered":"Gpi Group acquires Logiprem-F"},"content":{"rendered":"
Evolucare Technologies, Gpi’s French subsidiary, has acquired 100% of Logiprem-F, a key player in prescription software for neonatal and pediatric intensive care units.<\/p>\n
With this acquisition, Gpi Group becomes the leading software provider in Europe for the Critical Care sector<\/strong>, which encompasses software solutions dedicated to high-complexity care areas such as intensive care, operating rooms, and anesthesia.<\/p>\n
Reliable software for neonatal intensive care<\/h4>\n
Logiprem is France’s leading SaaS platform for neonatal intensive care. The software is based on proprietary, continuously updated drug and protocol databases, developed through a multidisciplinary approach involving physicians, pharmacists, nurses, and developers. The solution has reduced prescription errors by a factor of 13 and is recognized in France as the market leader for reliability in complex pediatric prescribing<\/strong>.<\/p>\n
The company manages a customer base of over 90 hospitals<\/strong>, primarily in France, with initial expansion into Spain and Germany. The transaction, structured on an Enterprise Value of 24 million euros<\/strong>, will strengthen Gpi Group’s offering in the Critical Care segment and support its expansion into key European markets.<\/p>\n